Skip Repeated Content

David Andersen is a seasoned corporate and M&A lawyer who regularly advises public and private companies, private equity sponsors and others in connection with mergers and acquisitions, joint ventures, debt and equity financings and other corporate matters.  David’s M&A practice is concentrated in the middle market, but includes transactions ranging from small acquisitions and divestitures by emerging growth companies to platform and bolt-on acquisitions to billion-dollar exits.  He has represented clients in a variety of industries, with an emphasis on technology, healthcare and media and entertainment companies. 

In addition to representing clients in connection with significant change of control and capital markets transactions, David represents companies in all phases of the corporate life cycle, including with respect to initial formation and capitalization, restructurings and recapitalizations, corporate governance and compliance with ongoing disclosure obligations under the federal securities laws.  In particular, he has extensive experience advising emerging growth companies and has assisted clients with structuring, developing and positioning numerous business enterprises for venture capital and private equity investment, growth through acquisitions and eventual sale or initial public offerings.  David also regularly serves as “outside general counsel” to companies, and has advised multiple clients for a dozen years or more, including representing a number of serial entrepreneurs in several different ventures.  In each case, David serves as a trusted adviser, anchoring a comprehensive cross-disciplinary legal team providing effective counsel that is rooted in a deep understanding of the client’s needs and objectives, as well as a desire to partner with clients to achieve their goals.

Practices

Representative Experience

  • Represented a biopharmaceutical company in a $750 million cross-border sale of select assets and in a subsequent $420 million public tender offer structured to return capital to domestic and international shareholders.
  • Represented a California-based IPA in the $545 million sale of its healthcare-related assets to a publicly traded health management company via a series of related preferred stock, common stock and lending transactions
  • Represented a global consumer electronics company in its $900 million sale to an international consumer brands and manufacturing company
  • Represented a transplantation laboratory in its sale to a national laboratory and diagnostics corporation
  • Represented a dental HMO in its sale to a leading national HMO
  • In transactions aggregating to approximately $500 million, represented a private equity buyer in the acquisition of an international franchising company with multiple restaurant brands, and subsequently represented the company in its sale to another restaurant franchisor and operator
  • Represented a media and entertainment company in the acquisition of one of the world’s most iconic kids’-focused entertainment brands, and in a subsequent joint venture with a prominent multinational corporation for the purpose of further developing such brand
  • Represented a regional chain of skilled nursing facilities in its acquisition of a company providing physical therapy services
  • Represented buyer in the acquisition of a leading international home networking brand
  • Represented significant shareholder in $3 billion sale of audio equipment and music streaming businesses
  • Represented a manufacturing company in a $500 million cross-border restructuring and business combination, and in its subsequent sale to a global consumer packaging company
  • Represented a medical device company in its sale to a leading international provider of renal care products and services
  • Represented the issuer in a $100 million venture capital investment and recapitalization transaction
  • Represented a fast-casual restaurant company in multiple rounds of private equity financing, totaling approximately $50 million
  • Represented a medical group in a restructuring and spin-off transaction with a hospital chain
  • Represented a party to a merger of publicly traded healthcare companies and with respect to the related S-4 registration statement
  • Represented the issuers and venture capital firms in numerous private placement financings in industries such as software, financial technology, digital health, gaming, social media and biotechnology
  • Numerous acquisitions and sales of public and private companies in industries such as software, hardware, telecom, financial technology, IT services, healthcare services, biotechnology and entertainment and new media
  • Served as issuer’s counsel in Rule 144A offerings, secondary public offerings, and the initial public offering of a technology company